Collectively, this is the first report to describe aspirin and sulindac sulfide as novel potential inhibitors of HMGA2, which can induce cytotoxicity in CRC cells overexpressing HMGA2 by inhibiting cell proliferation and migration through influencing inflammatory-response genes, the majority of which are involved in GPCR signaling. The gene discussed is HMGA2; the disease is colorectal carcinoma.